The brain is the body's most metabolically active organ and depends on continuous, well-regulated cerebral perfusion for every aspect of cognitive function. The cerebrovascular system — the network of arteries, arterioles, capillaries, venules, and veins that supplies the brain — delivers approximately 15% of cardiac output to an organ that is 2% of body mass. Disruption of this delivery, whether through acute events (stroke), chronic small vessel disease, or aging-related vascular changes, produces cognitive consequences that range from subtle executive dysfunction to frank dementia. The vascular substrate is foundational to longevity psychiatry.
The blood-brain barrier (BBB) is a specialized vascular structure that tightly regulates what enters the brain parenchyma from the bloodstream. The BBB protects the brain from circulating toxins, pathogens, and inflammatory mediators while allowing selective passage of nutrients, oxygen, and signaling molecules. With aging, vascular disease, and chronic inflammation, the BBB becomes increasingly permeable — "leaky" — allowing peripheral inflammatory signals and other harmful substances to reach the brain parenchyma in ways that contribute to neuroinflammation and cognitive decline. BBB integrity is increasingly recognized as a longevity-psychiatry target.
Cerebral small vessel disease is among the most clinically important and underrecognized contributors to cognitive decline. The small arteries and arterioles within the brain parenchyma can develop chronic changes — arteriolosclerosis, lipohyalinosis, microbleeds, lacunar infarcts — that produce the white matter hyperintensities seen on routine brain MRI in many older adults. These changes accumulate silently for decades and eventually produce executive dysfunction, processing speed slowing, gait changes, and increased risk of frank dementia. Their presence on imaging is a clinical signal that vascular optimization is overdue.
The cerebrovascular system shares risk factors with the systemic cardiovascular system, but the brain has specific vulnerabilities. Hypertension, dyslipidemia, diabetes, smoking, atrial fibrillation, and physical inactivity each contribute to both cardiovascular and cerebrovascular disease — and the brain effects often appear years to decades before the heart effects. The patient whose blood pressure has been suboptimally controlled for fifteen years may have substantial small vessel disease on imaging while remaining cardiovascularly asymptomatic. The clinical implication is that aggressive vascular risk factor management is brain medicine, with cardiac protection as a beneficial side effect.
The longevity-psychiatry workup includes vascular assessment in every patient in the acceleration window. Blood pressure with attention to the SPRINT-MIND target. Lipid panel with apoB measurement, not just LDL-C. Lipoprotein(a) once in a lifetime. Glucose and insulin status. Smoking status. Atrial fibrillation screening when indicated. Brain MRI is not routine for asymptomatic adults but should be considered in patients with significant cognitive complaints, family history of early-onset dementia, or accumulated vascular risk. White matter hyperintensities on MRI in a patient with cognitive complaints reframe the clinical conversation — the vascular substrate is contributing, and aggressive vascular optimization may slow or stabilize decline.